quinuclidines has been researched along with Bone Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aryee, DN; Ban, J; Kauer, M; Kofler, R; Kovar, H; Muehlbacher, K; Niedan, S; Schwentner, R | 1 |
| Aoki, Y; Hayashi, K; Higuchi, T; Igarashi, K; Inatani, H; Kato, T; Kimura, H; Nishida, H; Shimozaki, S; Shirai, T; Takeuchi, A; Tanzawa, Y; Tsuchiya, H; Yamamoto, N | 1 |
| Bergman, J; Bykov, VJ; Selivanova, G; Stridh, H; Westman, J; Wiman, KG; Zache, N | 1 |
1 trial(s) available for quinuclidines and Bone Neoplasms
| Article | Year |
|---|---|
Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-da
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Bone Neoplasms; Cross-Over Studies; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Palonosetron; Quinuclidines; Sarcoma; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Vomiting; Young Adult | 2015 |
2 other study(ies) available for quinuclidines and Bone Neoplasms
| Article | Year |
|---|---|
Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Microarray Analysis; Mutation; Quinuclidines; RNA, Small Interfering; Sarcoma, Ewing; Transcriptome; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2013 |
PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis.
Topics: Adenocarcinoma; Animals; Apoptosis; Aza Compounds; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Interactions; Drug Resistance, Neoplasm; Genes, p53; Humans; Lung Neoplasms; Mice; Mice, SCID; Mutation; Osteosarcoma; Quinuclidines; Transplantation, Heterologous; Tumor Cells, Cultured | 2005 |